$2.00
-0.02-0.99%
Last update: Nov 9, 1:02 AM

The average analyst price target for Adagene is $8.40, 309.8% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $7 to $10. The latest change came on Sep 10, 2026, when Chardan Capital initiated coverage of Adagene with a Buy rating and a $9 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months